Zobrazeno 1 - 8
of 8
pro vyhledávání: '"R A, Nelimark"'
Autor:
T E, Elliott, R P, Dinapoli, J R, O'Fallon, J E, Krook, J D, Earle, R F, Morton, R, Levitt, L K, Tschetter, B W, Scheithauer, D M, Pfeifle, D I, Twito, R A, Nelimark
Publikováno v:
Journal of neuro-oncology. 33(3)
We performed a randomized trial to compare survival distributions and toxicity of radiation therapy (RT) and DBD with RT and BCNU in patients with high-grade astrocytoma.A total of 238 patients with supratentorial grade 3 and grade 4 astrocytoma were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f5389ac5ae38e953cbfa3bec1b1c66c7
https://pubmed.ncbi.nlm.nih.gov/9195495
https://pubmed.ncbi.nlm.nih.gov/9195495
Autor:
J N, Ingle, S A, Kuross, J A, Mailliard, C L, Loprinzi, S H, Jung, R A, Nelimark, J E, Krook, H J, Long
Publikováno v:
Cancer. 74(6)
Doxorubicin generally is considered to be the most effective single chemotherapeutic agent for the treatment of breast cancer. The major cumulative dose-limiting toxicity is cardiac toxicity, which may be related to the formation of free radicals wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::51f036a20a82db78702957737ae77d7f
https://pubmed.ncbi.nlm.nih.gov/8082075
https://pubmed.ncbi.nlm.nih.gov/8082075
Autor:
J E, Krook, C L, Loprinzi, D J, Schaid, C G, Kardinal, J A, Mailliard, D M, Pfeifle, N M, Ellison, N F, Reuter, R A, Nelimark
Publikováno v:
Cancer. 65(3)
A prospective clinical trial was done to evaluate the efficacy and toxicity of cisplatin plus etoposide (VP-16) in patients with breast cancer who failed one previous chemotherapy regimen for advanced disease or relapsed within 12 months of adjuvant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::be70fa74fa0877d66403ae1fb082479c
https://pubmed.ncbi.nlm.nih.gov/2297632
https://pubmed.ncbi.nlm.nih.gov/2297632
Publikováno v:
JAMA. 249(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a9e4eb67b42974e42e0f2e99d3204da
https://pubmed.ncbi.nlm.nih.gov/6294353
https://pubmed.ncbi.nlm.nih.gov/6294353
Publikováno v:
American journal of clinical oncology. 6(5)
Sixteen patients, 13 of whom had received prior chemotherapy, were treated with vindesine for advanced malignant melanoma. Previous treatment included vinca alkaloids in six. Thirteen patients received vindesine, 4 mg/m2 and three received vindesine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::628332e23e6cf64946c383abd7b02533
https://pubmed.ncbi.nlm.nih.gov/6613921
https://pubmed.ncbi.nlm.nih.gov/6613921
Autor:
Institute of Medicine, Board on Health Sciences Policy, Committee on Strategies for Small-Number-Participant Clinical Research Trials, Suzanne T. Ildstad, Charles H. Evans, Jr
Clinical trials are used to elucidate the most appropriate preventive, diagnostic, or treatment options for individuals with a given medical condition. Perhaps the most essential feature of a clinical trial is that it aims to use results based on a l
Extending the Cox Model is aimed at researchers, practitioners, and graduate students who have some exposure to traditional methods of survival analysis. The emphasis is on semiparametric methods based on the proportional hazards model. The inclusion
Autor:
David S. Ettinger
In the United States alone, the incidence of new cases of thoracic neoplasms is over 180,000. Each year, over 170,000 individuals are expected to die of their cancer. Lung cancer is the most common of the thoracic neoplasms. It is the leading cause o